Connect with us
[ad_1] Here are the biggest calls on Wall Street on Thursday: Raymond James upgrades Biogen to outperform from market perform Raymond James said it likes the...
[ad_1] Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. [ad_2] Source link
[ad_1] Signage outside Intel headquarters in Santa Clara, California, on Monday, Jan. 30, 2023. David Paul Morris | Bloomberg | Getty Images Check out the companies...
[ad_1] Market Movers rounded up the best reactions from investors and analysts on Biogen . The experts discussed the biotech company after the Food and Drug...
[ad_1] The Food and Drug Administration on Thursday approved the Alzheimer’s treatment Leqembi, a pivotal decision that is expected to expand access to the expensive drug...
[ad_1] The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer’s treatment Leqembi, a step...
[ad_1] Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out...
[ad_1] The U.S. Food and Drug Administration said Tuesday it has granted accelerated approval to Biogen Inc.’s torferson, a treatment for a rare form of amyotrophic...
[ad_1] Medicare will not provide broader coverage of the Alzheimer’s drug Leqembi until it receives more evidence that the treatment is reasonable and necessary, according to...
[ad_1] CNN — A congressional investigation found that the US Food and Drug Administration’s “atypical collaboration” to approve a high-priced Alzheimer’s drug was “rife with irregularities.”...
[ad_1] A Tesla service and sales center is shown in Vista, California, June 3, 2022. Mike Blake | Reuters Check out the companies making headlines in...
[ad_1] Check out the companies making headlines before the bell: Tesla (TSLA) – Tesla CEO Elon Musk said he would refrain from selling any more Tesla...